]>
IRCT20160307026950N6 IRCT 2018-07-03 Esfahan University of Medical Sciences Comparison of low dose midazolam and etomidate for the Prevention of myoclonic Movements following etomidate Injection. Comparison of the Effects of Low-Dose Midazolam and Low-Dose etomidate on Prevention of Etomidate-Induced Myoclonus in electroconvulsive therapy 2017-06-22 anticipated 120 Complete https://irct.ir/trial/22210 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Patients are randomly assigned to three groups A, B, C, using the Random Allocation computer software, Blinding description: All drugs are in one form and in the form of a volume in the syringe by the researcher, and the hemodynamic changes are monitored and recorded, so the attending and the clinical caregiver and the evaluator do not understand the type of medication. 3 Myoclonic Movements. Intervention 1: Intervention group: . Intervention 2: Intervention group: . Intervention 3: Control group: . Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is No more information
public Seyedeh Maryam Mousavi
Charbaghbala
Isfahan Iran (Islamic Republic of) 817373673 +98 313372373 smmousavi717@gmail.com Esfahan University of Medical Sciences scientific Behzad Nazemroayasedeh
Hezar-Jerib
Isfahan Iran (Islamic Republic of) 8146713543 +98 31 3260 2020 behzad_nazem@med.mui.ac.ir Esfahan University of Medical Sciences Iran (Islamic Republic of) All Patients candidate Electroconvulsive Therapy ASA I,ASAII Age 6 - 15 years 9 years 15 years Both Severe cardiovascular disease kidney disease Liver disease Chronic respiratory disease drugs Allergy discontinue of cooperation intubation Prevention Prevention Placebo Intervention group: Intervention group: Control group: Myoclonus. Timepoint: After induction anesthesia. Method of measurement: Observation of myoclonic movements (0,1,2,3). Heart rate changes. Timepoint: Before the intervention, then after the intervention, , 5, 10, 20 minutes after intervention and then After The discharge time of recovery. Method of measurement: Pulse oximetry device. Mean arterial blood pressure. Timepoint: Before the intervention, then after the intervention, , 5, 10, 20 minutes after intervention and then After The discharge time of recovery. Method of measurement: non invasive blood pressure. Oxygen saturation. Timepoint: Before the intervention, then after the intervention, , 5, 10, 20 minutes after intervention and then After The discharge time of recovery. Method of measurement: Pulse oximetry device. Duration of seizure. Timepoint: After intervention. Method of measurement: In seconds using a chronometer. Recovery Duration. Timepoint: Since entering the recovery section until discharge time. Method of measurement: Minute with using a chronometer. Nausea and Vomiting. Timepoint: During the stay in the recovery. Method of measurement: In minutes using the chronometer. Headache. Timepoint: During the stay in the recovery. Method of measurement: Ask the patient about this complication. Muscle Pain. Timepoint: During the stay in the recovery. Method of measurement: Ask the patient about this complication. Esfahan University of Medical Sciences Approved 2017-05-25 Ethics committee of Isfahan University of Medical Sciences Hezar jarib street Isfahan Isfehan Iran (Islamic Republic of)